Breast Cancer Imaging and Therapy

In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival h...

Full description

Saved in:
Bibliographic Details
Other Authors: Seely, Jean (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_101387
005 20230714
003 oapen
006 m o d
007 cr|mn|---annan
008 20230714s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-7931-3 
020 |a 9783036579306 
020 |a 9783036579313 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-7931-3  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Seely, Jean  |4 edt 
700 1 |a Seely, Jean  |4 oth 
245 1 0 |a Breast Cancer Imaging and Therapy 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (228 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival has been achieved through early diagnosis of breast cancer with screening, allowing for more effective and targeted treatments. This reprint summarizes the latest evidence on the early detection of breast cancer and highlights areas where this may be improved. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Oncology  |2 bicssc 
653 |a contrast-enhanced spectral mammography 
653 |a breast cancer 
653 |a neoadjuvant chemotherapy 
653 |a complete response 
653 |a response evaluation criteria in solid tumors 
653 |a contrast-enhanced mammography 
653 |a magnetic resonance imaging 
653 |a image enhancement 
653 |a contrast media 
653 |a radiomics 
653 |a artificial intelligence 
653 |a breast 
653 |a cancer 
653 |a screening 
653 |a dense 
653 |a patient advocacy 
653 |a breast density 
653 |a breast density notification 
653 |a Canada 
653 |a mammography 
653 |a breast ultrasound 
653 |a breast cancer screening 
653 |a interval cancer 
653 |a mortality reduction 
653 |a breast MRI 
653 |a digital breast tomosynthesis 
653 |a molecular breast imaging 
653 |a overdetection 
653 |a Canadian National Breast Screening Study 
653 |a overdiagnosis 
653 |a overtreatment 
653 |a microsimulation 
653 |a mammographic screening 
653 |a randomization 
653 |a expertise 
653 |a guidelines 
653 |a evidenc 
653 |a epistemic trespassing 
653 |a evidence-based medicine 
653 |a risk factors 
653 |a screening mammography 
653 |a knowledge assessment 
653 |a barriers 
653 |a questionnaire examination 
653 |a DBT 
653 |a ultrasound 
653 |a benign biopsy 
653 |a stage shift 
653 |a registries 
653 |a prevention 
653 |a recommendations 
653 |a clinical practice 
653 |a breast screening 
653 |a high-risk breast screening 
653 |a dense breasts 
653 |a supplemental breast screening 
653 |a cardiovascular disease 
653 |a chemotherapy 
653 |a radiotherapy 
653 |a mortality 
653 |a adjuvant endocrine therapy 
653 |a adherence to treatment 
653 |a side effects 
653 |a tamoxifen 
653 |a aromatase inhibitors 
653 |a GnRH agonist 
653 |a questionnaire 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/7483  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/101387  |7 0  |z DOAB: description of the publication